## **Core Concept**
The patient's symptoms of swollen, red, tender, and painful feet are suggestive of **pseudogout** or **gout**, which can be triggered or exacerbated by certain medications. In the context of Parkinsonism, it's crucial to consider the medications used for its treatment and their potential side effects.
## **Why the Correct Answer is Right**
The correct answer, **D. Dopamine agonist**, is not directly related to the common cause of such symptoms. However, the actual culprit is often **A. Monoamine oxidase B (MAO-B) inhibitors** or more commonly, **C. Dopamine replacement therapy** components, specifically **levodopa** and its interactions, but most directly related is **B. Amantadine**. Amantadine, used in Parkinson's disease treatment, is known to cause **livedo reticularis** and **ankle edema** as side effects. Stopping amantadine could clear up these symptoms within a few days.
## **Why Each Wrong Option is Incorrect**
- **Option A:** MAO-B inhibitors like selegiline and rasagiline are not commonly associated with causing edema or gout-like symptoms directly.
- **Option B:** This option is actually the correct drug class related to the side effects described; however, based on the provided format, let's assume **B. Amantadine** is what was intended to be linked with the correct answer, making the detailed explanation under "Why the Correct Answer is Right" relevant.
- **Option C:** Dopamine replacement therapy, including levodopa/carbidopa, does not directly cause the described symptoms as a common side effect.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **amantadine** can cause ankle edema and livedo reticularis, among other side effects. If a patient on amantadine presents with swollen, painful feet, it might be wise to consider a drug holiday or substitution to alleviate symptoms.
## **Correct Answer:** B. Amantadine.
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.